Creative, non-traditional approach to highlight the clinically meaningful value of the product.
- Few local resources
- No global value dossier
- Mixed results in pivotal trials
- Co-primary endpoints were not met
- No Canadian comparator in trials
- Undeveloped clinical strategy
- PAS immediately adopted to the role of market access department to support company
- Supported the development of a Canadian medical deck to be used at pre-submission meeting
- Finalized a clinical summary using multiple sources, including clinical data, previous European HTA submissions and Health Canada submission
- Developed an innovative listing/pricing strategy in Quebec that would position product ahead of competitor that was getting significant funding through patient d’exception
- Developed key value messages for the client which resonated with physicians and were also adopted for use in the client’s commercial endeavors.